Canady HeliosTM Cold Plasma

The only technology that attacks
positive microscopic margins after
solid tumor removal without
damaging normal tissue.

Learn More

Canady HeliosTM Cold Plasma

Engineering Plasma Physics to Fight Cancer…

Learn More

Canady HeliosTM Cold Plasma

I have Hope Again…

Learn More

Canady HeliosTM Cold Plasma

Safe. No Side Effects.

Learn More

Canady HeliosTM Cold Plasma

Focused on the Fight

Learn More

TREATMENT SUCCESS

Jeremy Benharouch

Jeremy Benharouch shares his amazing story about how he’s been cancer-free for five years since his Canady Helios™ Cold Plasma treatment.

Amelda Bleeker

Amelda, a 40-year-old woman with inoperable Stage IV Intra-hepatic cholangiocarcinoma has groundbreaking surgery.

Molten Turner

Mr. Molten was treated intraoperatively with Canady Helios Cold Plasma after he underwent a Whipple Procedure.

Steven Gitelis, M.D. / Keith Millikan, M.D.

Rush University surgical oncologists discuss the ease and success of using Canady Helios™ Cold Plasma Treatments during their surgical procedures.

Dr. Aviram Nissan

Dr. Aviram Nissan, (Sheeba Medical Center) discusses how he “achieves the unachievable” using Canady Helios™ Cold Plasma.

Fox News Coverage of Canady Helios™ Cold Plasma Technology
Steven Gitelis, M.D. / Keith Millikan, M.D.

Rush University surgical oncologists discuss the ease and success of using Canady Helios™ Cold Plasma Treatments during their surgical procedures.

Dr. Aviram Nissan

Dr. Aviram Nissan, (Sheeba Medical Center) discusses how he “achieves the unachievable” using Canady Helios™ Cold Plasma.

Fox News Coverage of Canady Helios™ Cold Plasma Technology

US Medical Innovations Secures FDA Clearance for Canady Helios Cold Plasma™ Ablation System

TAKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI) announced today it has received FDA 510k Clearance (K240297) for the Canady Helios Cold Plasma™ (CHCP) Ablation System for the ablation of soft tissue during surgery. The CHCP system consists of the...
Read More

USMI TO DEBUT THE CANADY ROBOTIC AI SURGICAL SYSTEM AT THE FIRST GLOBAL SURGICAL ONCOLOGY SUMMIT JERUSALEM, ISRAEL JANUARY 2024

TAKOMA PARK, Md.--(BUSINESS WIRE)--The Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) and US Medical Innovations, LLC (USMI) are pleased to announce today a ground-breaking achievement in surgical and robotic...
Read More

Groundbreaking Results Using Canady Helios™ Cold Plasma Treatment Published in MDPI Journal “Cancers”

The First Cold Atmospheric Plasma Phase 1 Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for Cancer TAKOMA PARK, Md.--(BUSINESS WIRE)--The Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI) and...
Read More

USMI Receives FDA Approval for New Robotic Surgery Device – The Canady Flex RoboWrist™

TAKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI), a Biomedical and Life Science subsidiary of US Patent Innovations, LLC, announced today it has received FDA Approval for its Canady Flex RoboWrist™ to be used in open and laparoscopic procedures in...
Read More

JCRI-ABTS and USMI Reports Statistically Significant Results of the Canady Helios Cold Plasma Phase 1 Clinical Trial on Patients with Stage 4 and Recurrent Advanced Solid Tumors

TAKOMA PARK, Md.--(BUSINESS WIRE)—June 15, 2023 - The Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) and US Medical Innovations, LLC (USMI) announced significant positive results from the first FDA Phase I IDE...
Read More